Sunitinib Malate 50mg


Sunitinib, sold under the brand name Sutent, is a medication used to treat cancer. It is a small-molecule, multi-targeted receptor tyrosine kinase inhibitor that was approved by the FDA for the treatment of renal cell carcinoma and imatinib-resistant gastrointestinal stromal tumor on January 26, 2006. Sunitinib was the first cancer drug simultaneously approved for two different indications.

Specification/Additional Details

  • 1X7
  • Sutent
  • Sunitinib
  • Pfizer
  • gastrointestinal stromal tumor (GIST) and advanced renal cell carcinoma (RCC)


There are no reviews yet.

Be the first to review “Sunitinib Malate 50mg”

Your email address will not be published. Required fields are marked *

Shopping Cart
Open chat
Hey Patron, Medicines here are only delivered once you provide a Valid Prescription. Order Now!